Position in ANAB
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,815,222
+$975,063 QoQ
Shares Held
41,707
-16.2% QoQ
Ownership
0.143%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#63
of 211 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ANAB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026WELLS FARGO & COMPANY/MN holds $1,567,775,044 across 417 Biotechnology names. ANAB ranks #82 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
749,528 | $372,313,040 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
1,390,428 | $108,828,797 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
310,047 | $93,333,446 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
140,802 | $87,795,677 | |
| 5 | EXEL |
Exelixis, Inc.
|
717,840 | $39,057,673 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
178,780 | $33,481,916 | |
| 7 | ARGX |
Argenx SE
|
34,453 | $31,964,458 | |
| 8 | INCY |
Incyte Corp
|
255,064 | $28,914,053 |
All Filings in ANAB
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,815,222 | 41,707 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $1,840,159 | 33,180 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $1,076,594 | 22,207 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $420,809 | 13,743 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $739,881 | 33,328 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $211,497 | 11,377 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $147,228 | 11,120 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $907,746 | 27,097 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $665,694 | 26,564 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $131,763 | 5,851 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $107,549 | 5,021 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $273,691 | 15,239 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $476,566 | 23,430 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $358,605 | 16,480 | Shares | Defined | 2023-05-12 | |
| 2022-09-30 | $13,723 | 538 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $22,246 | 1,096 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $514,342 | 20,790 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $926,053 | 26,649 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $1,735,244 | 63,984 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $2,066,650 | 79,701 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $1,284,898 | 59,624 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $868,639 | 40,402 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $224,137 | 15,196 | Shares | Defined | 2020-11-05 | |
| 2020-06-30 | $427,205 | 19,123 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $208,798 | 14,777 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||